Showing results (121-130 of 263) with videos related to
Sort By:
Pageof 27
The Journal of the Royal College of General Practitioners|March 1, 1986
Evaluation of the mental function of the elderly in a general practiceS J Jachuck, S A Stobo, A SahgalMedical Physics|May 19, 2017
SU-E-T-253: Assessing Small-Volume Cord Biological Effective Dose for Repeat Spinal Stereotactic Body Radiotherapy TreatmentsL Ma, A Sahgal, N Kirby, et al.Clinical Neuropharmacology|August 1, 1992
Weak antiparkinsonian activity of the D1 agonist C-APB (SKF 82958) and lack of synergism with a D2 agonist in primatesN M Rupniak, S Boyce, M Steventon, et al.Psychopharmacology|January 1, 1988
Chronic administration of a selective dopamine D-2 agonist: factors determining behavioral tolerance and sensitizationM T Martin-Iverson, S M Stahl, S D IversenNeurology|April 1, 1990
CCK-8S inhibits L-dopa-induced dyskinesias in parkinsonian squirrel monkeysS Boyce, N M Rupniak, M Steventon, et al.Brain Research|December 14, 1981
Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathwayS B Dunnett, A Björklund, U Stenevi, et al.Brain Research|December 21, 1981
Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesionsS B Dunnett, A Björklund, U Stenevi, et al.Neuropeptides|August 1, 1993
Failure of intravenous pentagastrin challenge to induce panic-like effects in rhesus monkeysN M Rupniak, L Schaffer, P Siegl, et al.Brain Research|June 29, 1981
Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesionsS B Dunnett, A Björklund, U Stenevi, et al.Nature|February 5, 1981
Functional reactivation of the deafferented neostriatum by nigral transplantsA Björklund, U Stenevi, S B Dunnett, et al.Pageof 27